Pro-Cure’s existing investors include White Rose Technology Seedcorn Fund, Yorkshire & Humber Equity Fund, Yorkshire Cancer Research, the University of York and Reef Securities Limited.

We are always willing to talk to organisations or individuals interested in making an equity investment in the company or in providing alternative forms of funding.

For further information please contact Dr Mick McLean, CEO